Sed after the treatment, whereas anti-GM1 monoclonal antibody reactivity was increased.
Sed after the treatment, whereas anti-GM1 monoclonal antibody reactivity was increased. This indicates that the neuraminidase-treatment transformed GD1a-like LOS into…